Primary Insomnia Clinical Trial
Official title:
A Double-blind, Parallel Group, Randomised, Placebo Controlled Study of Efficacy and Safety of Circadin® 2 mg in the Treatment of Insomnia Patients With Low Endogenous Melatonin
This is a randomised, placebo controlled study to evaluate the efficacy of a 3 week treatment period with Circadin® 2 mg in shortening sleep latency in patients with primary insomnia aged 18-80 with melatonin deficiency.
Studies throughout the world have shown that insomnia is a common complaint that occurs in
10-50% of the population depending on age, sex and country. Among the wide variety of
available treatments of sleep disturbances, the most commonly prescribed hypnotics are the
benzodiazepines (BZD) and non-BZD hypnotics.
However, these hypnotics were often associated with rebound, dependency, tolerance, higher
risk of falls mainly in the elderly population, anterograde memory disturbances and increased
risk for motor accidents the next day.
In response to the unmet clinical need for a safe and efficacious alternative treatment for
primary insomnia, that in addition to treating quantitative sleep problems, would improve
sleep quality and daytime functioning, a clinical development program on melatonin for the
treatment of primary insomnia was initiated.
This study is conducted using a randomised, double-blind, placebo controlled parallel group
design, after a single-blind placebo period. Primary insomnia patients aged 18-80 will be
screened for entry into the study.
After the initial 3 weeks double-blind treatment period, patients will be given the option to
enter a six-month double-blind continuation study.
Primary parameter is sleep latency, secondary parameter is sleep maintenance. Exploratory
parameters are total sleep time, sleep quality, morning alertness and quality of life.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03461666 -
Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia
|
N/A | |
| Recruiting |
NCT02243501 -
Better Nights, Better Days for Typically Developing Children
|
N/A | |
| Completed |
NCT01636791 -
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
|
Phase 3 | |
| Completed |
NCT00770510 -
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
|
Phase 2/Phase 3 | |
| Completed |
NCT00520832 -
A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys
|
Phase 2 | |
| Recruiting |
NCT00415714 -
Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia
|
N/A | |
| Terminated |
NCT00420810 -
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
|
Phase 3 | |
| Completed |
NCT00178048 -
Paroxetine in the Treatment of Chronic Primary Insomnia
|
Phase 4 | |
| Completed |
NCT00816673 -
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
|
Phase 2 | |
| Completed |
NCT01960452 -
A High Density EEG Comparison of Sleep Patterns in Insomnia
|
N/A | |
| Completed |
NCT01957111 -
Metabolomics of Insomnia-Related Hyperarousal
|
N/A | |
| Completed |
NCT01181232 -
A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients
|
Phase 4 | |
| Completed |
NCT00784875 -
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
|
Phase 2 | |
| Completed |
NCT00551148 -
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
|
Phase 2 | |
| Completed |
NCT00352144 -
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
|
Phase 3 | |
| Completed |
NCT02290405 -
Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
|
||
| Completed |
NCT03314441 -
Effects of Regular Practice of Yoga on Subjective and Objective Sleep Quality in Primary Insomnia
|
N/A | |
| Completed |
NCT00792298 -
Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
|
Phase 2 | |
| Completed |
NCT01021852 -
Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)
|
Phase 2 | |
| Completed |
NCT01719315 -
Neurophysiologic Correlates of Hypersomnia
|